Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $4,264 - $6,700
-150 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$11.71 - $30.29 $1,756 - $4,543
-150 Reduced 50.0%
150 $5,000
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $942 - $1,375
-50 Reduced 14.29%
300 $6,000
Q1 2019

May 10, 2019

BUY
$10.65 - $25.75 $3,727 - $9,012
350 New
350 $8,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Global Wealth Management Investment Advisory, Inc. Portfolio

Follow Global Wealth Management Investment Advisory, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.